yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q27851656-F8AFA40A-F59A-499F-9002-08E1B772BB24
Q27851656-F8AFA40A-F59A-499F-9002-08E1B772BB24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851656-F8AFA40A-F59A-499F-9002-08E1B772BB24
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.
P1476
Q27851656-F8AFA40A-F59A-499F-9002-08E1B772BB24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27851656-F8AFA40A-F59A-499F-9002-08E1B772BB24
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4d34f3045259d1063818f49532e035df95d01b39
P1476
Phase II, open-label, single-a
......
Kit mutation or amplification.
@en